Novartis Launches 3-Day Feline NSAID


Novartis Animal Health launched Onsior (robenacoxib) tablets, a three-day non-steroidal anti-inflammatory drug for postoperative cats, the Greensboro, N.C., company reported today.

The drug is indicated for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration. It is the first multidose oral NSAID to be approved for cats, Novartis reported.

The drug’s short blood half-life causes the active ingredient to be quickly eliminated from the blood while persisting longer at the site of inflamed tissue, allowing for once-a-day administration for up to three days, the company reported.

Side effects observed during a clinical field trial and six-month safety study included surgical site bleeding, infected surgery sites, lethargy, vomiting and inappetence.

The drug is indicated for cats weighing 5.5 pounds or heavier and at least 6 months old for a maximum of three days. The drug should not be used in cats that have a hypersensitivity to robenacoxib or known intolerance to NSAIDs and should not be administered in conjunction with any other oral or injectable NSAID or corticosteroid, according to Novartis.


Edit Module
Edit ModuleShow Tags

Archive »Read More

Texas Board Accuses Kristen Lindsey of Animal Cruelty

A legal filing reveals that the veterinarian’s mother also made light of a cat’s death and that the animal was likely a patient at the same clinic.

Texas Wants to Revoke ‘Bow Kill’ Vet’s License

Dr. Kristen Lindsey didn’t respond to a disciplinary order, leading to a possible hearing before an administrative law judge.

A Vet School Freshman at 57

After volunteer work and careers in music, real estate and farming, Craig Mullenax embarked on a new challenge.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags


Show More...
Edit Module
Edit Module
Edit Module